What measures are being taken by European Union authorities to mitigate potential shortages stemming from supply-chain and manufacturing disruptions? In this podcast we feature an article that outlines the guidance issued by EU authorities to provide flexibility in sourcing for crucial medicines for the treatment of COVID-19. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Providing regulatory flexibility for sourcing activities
- The exceptional change-management process
- Other measures in the EU to mitigate drug shortages